EP Patent

EP2238973A1 — Lyophilized preparations of proteasome inhibitors

Assigned to Cephalon France SAS · Expires 2010-10-13 · 16y expired

What this patent protects

Lyophilized preparations of proteasome inhibitors are described, as well as methods for their production and use.

USPTO Abstract

Lyophilized preparations of proteasome inhibitors are described, as well as methods for their production and use.

Drugs covered by this patent

Patent Metadata

Patent number
EP2238973A1
Jurisdiction
EP
Classification
—
Expires
2010-10-13
Drug substance claim
No
Drug product claim
No
Assignee
Cephalon France SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.